6th September 2021 | Pharma Updates
Telangana to develop B-Hub as a biopharmaceutical focus
Hyderabad is a major R&D centre with institutes like IICT, CCMB, CDFD and more than 800 life sciences organizations.
DRL join hands with Citius Pharma
In March 2016, DRL had acquired the exclusive rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai.
Serum Institute paid Rs 3000 crore for 50% stake in SCHOTT Kaisha
SII paid Rs 3000 crore for a 50% stake in the SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry.
5 drug companies riding the vax wave
Ever since the outbreak of Coronavirus, the Indian pharma industry has shown a recovery. It was one of the highperforming sectors of last year.
Lupin gets permit to make new TB drug
The drug company has received a license to make the anti-TB drug pretomanid from non-profit drug developer, TB Alliance.
Legacy drug firm which sold 'Swadeshi' dysentery medication to Afghans waits and watches after Taliban takeover
The organization which was set up as a ‘Swadeshi enterprise’ meant to take on the stranglehold of British drug makers.
Antibiotic Overuse is Driving Drug Resistant Bacteria: ICMR
The research found a sustained increase in drug-resistant bacterias. This has resulted in medical doctors struggling to treat certain infections with medicines.